Medical Imaging (6637) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 醫影

Medical Imaging (6637) reported revenue of NT$120.6 million for Oct 2026, +107.1% year on year and +5.5% from the previous month. Revenue for Jan–Oct 2026 was NT$849.1 million (-12.7% year on year).

Year-on-year revenue growth: 3 months in a row. →

In Oct 2026, it ranked No. 65 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$102.1 million24/10Nov 2024 NT$54.2 millionDec 2024 NT$54.9 millionJan 2025 NT$49 millionFeb 2025 NT$31.6 million25/02Mar 2025 NT$44.3 millionApr 2025 NT$59.5 millionMay 2025 NT$525.6 millionJun 2025 NT$59.6 million25/06Jul 2025 NT$55.1 millionAug 2025 NT$42.9 millionSep 2025 NT$47.3 millionOct 2025 NT$58.2 million25/10Nov 2025 NT$40 millionDec 2025 NT$151.3 millionJan 2026 NT$43.2 millionFeb 2026 NT$93.7 million26/02Mar 2026 NT$52.7 millionApr 2026 NT$45.1 millionMay 2026 NT$47.1 millionJun 2026 NT$238.7 million26/06Jul 2026 NT$50.4 millionAug 2026 NT$43.3 millionSep 2026 NT$114.3 millionOct 2026 NT$120.6 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$120.6 million+107.1%+5.5%
Sep 2026NT$114.3 million+141.6%+163.7%
Aug 2026NT$43.3 million+0.9%-14.0%
Jul 2026NT$50.4 million-8.6%-78.9%
Jun 2026NT$238.7 million+300.8%+406.9%
May 2026NT$47.1 million-91.0%+4.4%
Apr 2026NT$45.1 million-24.2%-14.5%
Mar 2026NT$52.7 million+19.1%-43.7%
Feb 2026NT$93.7 million+196.3%+117.1%
Jan 2026NT$43.2 million-11.9%-71.5%
Dec 2025NT$151.3 million+175.7%+278.7%
Nov 2025NT$40 million-26.2%-31.4%
Oct 2025NT$58.2 million-43.0%+23.1%
Sep 2025NT$47.3 million-64.3%+10.1%
Aug 2025NT$42.9 million-12.0%-22.1%
Jul 2025NT$55.1 million-9.2%-7.4%
Jun 2025NT$59.6 million+26.8%-88.7%
May 2025NT$525.6 million+955.9%+783.3%
Apr 2025NT$59.5 million-46.5%+34.4%
Mar 2025NT$44.3 million-20.8%+40.0%
Feb 2025NT$31.6 million-25.8%-35.5%
Jan 2025NT$49 million-31.1%-10.7%
Dec 2024NT$54.9 million-55.9%+1.3%
Nov 2024NT$54.2 million-25.7%-46.9%
Oct 2024NT$102.1 million+148.9%-22.8%

Jan–Oct 2026 cumulative: NT$849.1 million (-12.7% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Medical Imaging vs PEC / Medical Imaging vs Lotus Pharm / Medical Imaging vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

主因本月醫療儀器設備銷售收入較去年同期為高。

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16